Cardiovascular disease
Item
2. uncontrolled or severe cardiovascular disease.
boolean
C0007222 (UMLS CUI [1])
Pancreatitis or coagulopathy
Item
3. history of pancreatitis or overt coagulopathy (prior cerebrovascular accident or hemorrhage, transient ischemic attack or deep venous thrombosis).
boolean
C0030305 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
Bilirubin, creatinine, or amylase measurement
Item
4. elevations in bilirubin, creatinine, or amylase that may suggest impaired hepatic, renal, or pancreatic function must be considered as potentially serious obstacles for safe tolerance of the therapy prescribed in this protocol.
boolean
C1278039 (UMLS CUI [1])
C0201976 (UMLS CUI [2])
C0201883 (UMLS CUI [3])
Study agents
Item
5. prior use of the agents administered in this protocol for other non-malignant disease may reduce the likelihood of beneficial outcome, and should also be considered prior to enrolling patients.
boolean
C1521826 (UMLS CUI [1])
Pregnancy
Item
6. treatment under this protocol would expose an unborn child to significant risks.
boolean
C0032961 (UMLS CUI [1])
Contraception
Item
women and men of reproductive potential should agree to use an effective means of birth control.
boolean
C0700589 (UMLS CUI [1])
All, fab l1-or l2 or aul
Item
7. unequivocal histologic diagnosis of acute lymphoblastic leukemia (all), fab l1-or l2 or acute undifferentiated leukemia (aul).
boolean
C0023449 (UMLS CUI [1])
C0457324 (UMLS CUI [2])
C0457325 (UMLS CUI [3])
C0280141 (UMLS CUI [4])
Age
Item
8. age ≥ 15 years
boolean
C0001779 (UMLS CUI [1])
Prior treatment
Item
9. prior treatment: no prior treatment for leukemia, with three permissible exceptions:
boolean
C1514463 (UMLS CUI [1])
Leukapheresis, hydroxyurea treatment or radiotherapy to head
Item
i. emergency leukapheresis; ii. emergency treatment for hyperleukocytosis with hydroxyurea; iii. cranial rt for cns leukostasis (one dose only).
boolean
C0023416 (UMLS CUI [1])
C0020402 (UMLS CUI [2])
C1997353 (UMLS CUI [3])